Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Kidney Neoplasms × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Kidney Neoplasms 1 Kidney Diseases 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1

Interventions

Sunitinib 2 belzutifan 1 avelumab 1 Everolimus 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02684006 2025-07-30

JAVELIN Renal 101

Pfizer

Phase 3 Completed

886 enrolled 37 charts 1 FDA

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡